Kelly Schick C4 Therapeutics, Inc. (CCCC) insider trading activity

CCCC Quotes by TradingView

Kelly Schick is Chief People Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 56,488 shares of CCCC, which is worth approximately $228,776. The most recent transaction as insider was on Nov 07, 2024, when has been sold 1,102 shares (Common Stock) at a price of $6.04 per share, resulting in proceeds of $6,656. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.5K
8.11% 3M change
111.68% 12M change
Total Value Held $228,776

Kelly Schick Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2024
SELL
Payment of exercise price or tax liability
$6,656 $6.04 p/Share
1,102 Reduced 1.91%
56,488 Common Stock
Nov 07 2024
BUY
Exercise of conversion of derivative security
-
3,750 Added 6.11%
57,590 Common Stock
Sep 16 2024
SELL
Payment of exercise price or tax liability
$4,203 $6.36 p/Share
661 Reduced 1.21%
53,840 Common Stock
Sep 16 2024
BUY
Exercise of conversion of derivative security
-
2,250 Added 3.96%
54,501 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
27,300 Added 34.32%
52,251 Common Stock
Feb 13 2024
SELL
Payment of exercise price or tax liability
$11,329 $6.53 p/Share
1,735 Reduced 6.5%
24,951 Common Stock
Aug 30 2023
SELL
Payment of exercise price or tax liability
$1,936 $2.93 p/Share
661 Reduced 2.42%
26,686 Common Stock
Aug 30 2023
BUY
Exercise of conversion of derivative security
-
2,250 Added 7.6%
27,347 Common Stock
Feb 13 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 44.35%
25,097 Common Stock
Jan 30 2023
SELL
Payment of exercise price or tax liability
$10,121 $7.78 p/Share
1,301 Reduced 20.33%
5,097 Common Stock
Jan 30 2023
BUY
Exercise of conversion of derivative security
-
3,750 Added 36.95%
6,398 Common Stock
May 25 2022
BUY
Exercise of conversion of derivative security
-
3,750 Added 50.0%
3,750 Common Stock

Also insider at

AMAG
AMAG PHARMACEUTICALS, INC.
Chief Human Resources Officer
KS

Kelly Schick

Chief People Officer
Waltham, MA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CCCC